chr12-116750115-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001382266.1(RNFT2):c.358G>A(p.Gly120Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000307 in 1,563,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001382266.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNFT2 | NM_001382266.1 | c.358G>A | p.Gly120Ser | missense_variant | 4/11 | ENST00000257575.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNFT2 | ENST00000257575.9 | c.358G>A | p.Gly120Ser | missense_variant | 4/11 | 5 | NM_001382266.1 | P1 | |
RNFT2 | ENST00000392549.7 | c.358G>A | p.Gly120Ser | missense_variant | 4/12 | 5 | P1 | ||
RNFT2 | ENST00000407967.7 | c.358G>A | p.Gly120Ser | missense_variant | 4/11 | 5 | |||
RNFT2 | ENST00000547718.5 | c.*315G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152188Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000319 AC: 45AN: 1411526Hom.: 0 Cov.: 33 AF XY: 0.0000229 AC XY: 16AN XY: 698976
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152306Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.358G>A (p.G120S) alteration is located in exon 4 (coding exon 3) of the RNFT2 gene. This alteration results from a G to A substitution at nucleotide position 358, causing the glycine (G) at amino acid position 120 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at